May 06, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Federal Circuit Clarifies Limits of Issue Preclusion Between IPRs and District Courts
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Federal Circuit Clarifies Limits of Issue Preclusion Between IPRs and District Courts
Biotechnology

Federal Circuit Clarifies Limits of Issue Preclusion Between IPRs and District Courts

By Newsroom
Last updated: November 2, 2025
1 Min Read
Share


The Federal Circuit’s recent decision last week in Inland Diamond Prods. Co. v. Cherry Optical Inc., offers an important reminder for patent litigators: a PTAB’s factual finding in an inter partes review (IPR) does not automatically bind a district court. The case underscores that issue preclusion has clear boundaries when different forums apply different standards of proof.

Background of the Dispute

The dispute arose after the PTAB found certain independent claims of two lens-related patents unpatentable as obvious while upholding several other dependent claims. Later, in district court litigation over the same…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Vancouver’s earthquake-resilient water supply tunnel hits milestone

Environmental Science
October 26, 2025

FinTech Arabia — The Premier B2B Intelligence Hub & News Aggregator for the MENA Financial Revolution

Executive Summary The Middle East and North Africa (MENA) are undergoing a profound economic renaissance,…

May 6, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Federal Circuit Lifts § 101 Barrier on Smart Dumbbells

On August 11, 2025, the Federal Circuit reversed the District of Utah’s ruling that all but one of the claims…

Biotechnology
December 14, 2025

The Crucial Role of Patent Due Diligence in Mergers & Acquisitions: Spotting Patent Litigation Risks Before Closing a Deal

In today’s rapidly evolving business landscape, mergers and acquisitions (“M&A”) remain a common strategic priority for companies aiming to grow,…

Biotechnology
April 5, 2025

Regents of the U. of Cal. v. Broad Inst. – “Just The Facts, Ma’am.” |

The central theme in this interference decision involving U.S. Pat. No. 8,697,359 is the amount and type of evidence required…

Biotechnology
June 6, 2025

Sonos, Inc. v. Google LLC: CAFC Leaves Expanded Role for Prosecution Laches in Limbo

The practice of serially filing continuation applications through a patent’s lifetime has come under increased pressure in recent years from…

Biotechnology
November 9, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

FinTech Arabia — The Premier B2B Intelligence Hub & News Aggregator for the MENA Financial Revolution
May 6, 2026
Healthcare Infrastructure Finance Market Growth Drivers and Opportunities
May 5, 2026
Pharma Regulatory Management Systems Market Industry Analysis and Forecast
May 5, 2026
Direct-to-Consumer Laboratory Testing Market Growth Drivers and Opportunities
May 5, 2026

Life Science Magazines

Guide: Navigating 5 overlooked ADC manufacturing challenges
May 5, 2026
Unlocking Proteomics: Longitudinal Monitoring in CLL
May 4, 2026
Beyond Launch: 5 Ways Therapy Success Is Being Redefined
May 2, 2026
Radiopharmaceuticals: Moving Beyond Innovation to Real-World…
May 2, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?